These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 37153557)

  • 1. Role of macrophages in pulmonary arterial hypertension.
    Zhang MQ; Wang CC; Pang XB; Shi JZ; Li HR; Xie XM; Wang Z; Zhang HD; Zhou YF; Chen JW; Han ZY; Zhao LL; He YY
    Front Immunol; 2023; 14():1152881. PubMed ID: 37153557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Yaku A; Inagaki T; Asano R; Okazawa M; Mori H; Sato A; Hia F; Masaki T; Manabe Y; Ishibashi T; Vandenbon A; Nakatsuka Y; Akaki K; Yoshinaga M; Uehata T; Mino T; Morita S; Ishibashi-Ueda H; Morinobu A; Tsujimura T; Ogo T; Nakaoka Y; Takeuchi O
    Circulation; 2022 Sep; 146(13):1006-1022. PubMed ID: 35997026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension.
    Zawia A; Arnold ND; West L; Pickworth JA; Turton H; Iremonger J; Braithwaite AT; Cañedo J; Johnston SA; Thompson AAR; Miller G; Lawrie A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):430-445. PubMed ID: 33147993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.
    Liang S; Desai AA; Black SM; Tang H
    Adv Exp Med Biol; 2021; 1303():275-303. PubMed ID: 33788198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
    Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.
    Hiraishi K; Kurahara LH; Ishikawa K; Go T; Yokota N; Hu Y; Fujita T; Inoue R; Hirano K
    J Smooth Muscle Res; 2022; 58(0):50-62. PubMed ID: 35944979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.
    Wang RR; Yuan TY; Wang JM; Chen YC; Zhao JL; Li MT; Fang LH; Du GH
    Pharmacol Res; 2022 Jun; 180():106238. PubMed ID: 35504356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension.
    Chi PL; Cheng CC; Hung CC; Wang MT; Liu HY; Ke MW; Shen MC; Lin KC; Kuo SH; Hsieh PP; Wann SR; Huang WC
    Int J Biol Sci; 2022; 18(1):331-348. PubMed ID: 34975336
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Peng Y; Dai J; Zhao YY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in Pulmonary Arterial Hypertension.
    Klouda T; Yuan K
    Adv Exp Med Biol; 2021; 1303():351-372. PubMed ID: 33788202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells in the pathogenesis of pulmonary arterial hypertension.
    Evans CE; Cober ND; Dai Z; Stewart DJ; Zhao YY
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33509961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Liu P; Zhang A; Ding Z; Dai D; Li B; Liu SF; Xu J; Cheng Z; Zhao S; Zhao X; Dong J
    Am J Respir Cell Mol Biol; 2022 Nov; 67(5):574-588. PubMed ID: 35972996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
    BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corosolic acid ameliorates vascular remodeling in pulmonary arterial hypertension via the downregulation of STAT3 signaling.
    Kawade A; Yamamura A; Kondo R; Suzuki Y; Yamamura H
    J Pharmacol Sci; 2023 Feb; 151(2):119-127. PubMed ID: 36707177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Cells in Pulmonary Arterial Hypertension.
    Ni S; Ji T; Dong J; Chen F; Feng H; Zhao H; Chen D; Ma W
    Heart Lung Circ; 2022 Jul; 31(7):934-943. PubMed ID: 35361533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    van Uden D; Boomars K; Kool M
    Front Immunol; 2019; 10():11. PubMed ID: 30723471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.
    Wang J; Liu C; Huang SS; Wang HF; Cheng CY; Ma JS; Li RN; Lian TY; Li XM; Ma YJ; Jing ZC
    Eur J Pharmacol; 2024 May; 970():176492. PubMed ID: 38503401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Drugs and Therapies in Pulmonary Arterial Hypertension.
    Shah AJ; Beckmann T; Vorla M; Kalra DK
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management.
    Zhang Y; Li X; Li S; Zhou Y; Zhang T; Sun L
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39125996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple roles of macrophage migration inhibitory factor in pulmonary hypertension.
    Jalce G; Guignabert C
    Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L1-L9. PubMed ID: 31577159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.